secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nkarta, Inc. (NKTX)
CIK:        0001787400
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0000950170-22-006547
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nkarta completes $215.5M public offering of 15.3M shares at $15/sh
------------------------------------------------------------------

- Sold 13.33M firm shares plus 2M option shares at $15.00/sh.
- Net proceeds ~$215.5M after underwriting discounts and expenses.
- Proceeds to fund NKX101, NKX019 clinical development, preclinical programs, and manufacturing.
- Underwriters: Cowen, SVB Securities, Evercore.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787400/000095017022006547/0000950170-22-006547-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787400/000095017022006547/nktx-20220428.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-006547

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer